Global Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Forecast 2024-2030- Product Image

Sale

Global Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Forecast 2024-2030

Report
186 Pages
March 2024
Region: Global
360iResearch™
ID: 5925172

UP TO €843EUR$875USD£721GBP OFF until Dec 31^st 2024

The Oncology Precision Medicine Market size was estimated at USD 7.34 billion in 2023, USD 7.67 billion in 2024, and is expected to grow at a CAGR of 9.10% to reach USD 13.51 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Oncology Precision Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oncology Precision Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Oncology Precision Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca PLC, B. J. Madan & Co., Bayer AG, Bristol-Myers Squibb Company, Cepheid Inc., Eli Lilly & Company, F. Hoffmann-La Roche Ltd, Genome Medical boasts, GSK PLC, IQVIA Inc., Laboratory Corporation of America Holding, llumina, Inc., Merck KGaA, Novartis AG, OneOme, LLC, Pfizer Inc., Rain Oncology Inc., Relay Therapeutics, Sanofi S.A., Strata Oncology, Inc., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Inc., Variantyx, Inc., and Xilis, Inc.

Market Segmentation & Coverage

This research report categorizes the Oncology Precision Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Cell & Gene Therapy
- Inhibitor drugs
- Monoclonal Antibodies
Cancer Type
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
End-use
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Oncology Precision Medicine Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oncology Precision Medicine Market?
What are the technology trends and regulatory frameworks in the Oncology Precision Medicine Market?
What is the market share of the leading vendors in the Oncology Precision Medicine Market?
Which modes and strategic moves are suitable for entering the Oncology Precision Medicine Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Oncology Precision Medicine Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of cancer among the global population
5.1.1.2. Government initiatives to promote precision medicine
5.1.1.3. Increasing adoption of genetic testing to enhance precision medicine
5.1.2. Restraints
5.1.2.1. Limited reimbursement available for oncology precision medicine treatment
5.1.3. Opportunities
5.1.3.1. Ongoing R&D to develop personalized medicine to treat cancer
5.1.3.2. Advances in clinical next-generation sequencing for tumor tissue and liquid biopsy
5.1.4. Challenges
5.1.4.1. Complex regulatory framework surrounding precision oncology
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Oncology Precision Medicine Market, by Type

6.1. Introduction
6.2. Cell & Gene Therapy
6.3. Inhibitor drugs
6.4. Monoclonal Antibodies

7. Oncology Precision Medicine Market, by Cancer Type

7.1. Introduction
7.2. Breast Cancer
7.3. Cervical Cancer
7.4. Colorectal Cancer
7.5. Lung Cancer
7.6. Prostate Cancer

8. Oncology Precision Medicine Market, by End-use

8.1. Introduction
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies

9. Americas Oncology Precision Medicine Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oncology Precision Medicine Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Oncology Precision Medicine Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. AstraZeneca PLC
13.1.3. B. J. Madan & Co.
13.1.4. Bayer AG
13.1.5. Bristol-Myers Squibb Company
13.1.6. Cepheid Inc.
13.1.7. Eli Lilly & Company
13.1.8. F. Hoffmann-La Roche Ltd
13.1.9. Genome Medical boasts
13.1.10. GSK PLC
13.1.11. IQVIA Inc.
13.1.12. Laboratory Corporation of America Holding
13.1.13. llumina, Inc.
13.1.14. Merck KGaA
13.1.15. Novartis AG
13.1.16. OneOme, LLC
13.1.17. Pfizer Inc.
13.1.18. Rain Oncology Inc.
13.1.19. Relay Therapeutics
13.1.20. Sanofi S.A.
13.1.21. Strata Oncology, Inc.
13.1.22. Takeda Pharmaceutical Company Limited
13.1.23. Thermo Fisher Scientific, Inc.
13.1.24. Variantyx, Inc.
13.1.25. Xilis, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. ONCOLOGY PRECISION MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. ONCOLOGY PRECISION MEDICINE MARKET SIZE, 2023 VS 2030
FIGURE 3. ONCOLOGY PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ONCOLOGY PRECISION MEDICINE MARKET DYNAMICS
FIGURE 7. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 10. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ONCOLOGY PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ONCOLOGY PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ONCOLOGY PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ONCOLOGY PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY INHIBITOR DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 10. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 16. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. CANADA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. CHINA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. INDIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. ITALY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. POLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. QATAR ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. ONCOLOGY PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. ONCOLOGY PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. ONCOLOGY PRECISION MEDICINE MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
AstraZeneca PLC
B. J. Madan & Co.
Bayer AG
Bristol-Myers Squibb Company
Cepheid Inc.
Eli Lilly & Company
F. Hoffmann-La Roche Ltd
Genome Medical boasts
GSK PLC
IQVIA Inc.
Laboratory Corporation of America Holding
llumina, Inc.
Merck KGaA
Novartis AG
OneOme, LLC
Pfizer Inc.
Rain Oncology Inc.
Relay Therapeutics
Sanofi S.A.
Strata Oncology, Inc.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific, Inc.
Variantyx, Inc.
Xilis, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.67 Billion
Forecasted Market Value ( USD ) by 2030	$ 13.51 Billion
Compound Annual Growth Rate	9.1%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3253EUR$3,374USD£2,782GBP €3614EUR$3,749USD£3,091GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4121EUR$4,274USD£3,524GBP €4579EUR$4,749USD£3,916GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4988EUR$5,174USD£4,266GBP €5543EUR$5,749USD£4,740GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5856EUR$6,074USD£5,008GBP €6507EUR$6,749USD£5,565GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7591EUR$7,874USD£6,493GBP €8435EUR$8,749USD£7,214GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecast

Global Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Forecast 2024-2030

Precision Medicine Market Size, Share & Trends Analysis Report By Application ((Diagnostics (Genetic Tests, Esoteric Tests), Therapeutics (Pharmaceuticals, Medical Devices)), By End Use, By Region, And Segment Forecasts, 2023 - 2030

Oncology Precision Medicine Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

Precision Oncology Market Report: Trends, Forecast and Competitive Analysis to 2030